statistiche ricercatore

Continente	#
NA - Nord America	501
AS - Asia	420
EU - Europa	367
SA - Sud America	72
AF - Africa	37
Continente sconosciuto - Info sul continente non disponibili	24
Totale	1.421

Nazione	#
US - Stati Uniti d'America	479
IT - Italia	212
SG - Singapore	168
CN - Cina	77
VN - Vietnam	75
BR - Brasile	61
HK - Hong Kong	31
DE - Germania	30
FR - Francia	25
ZA - Sudafrica	21
IE - Irlanda	18
GB - Regno Unito	14
RU - Federazione Russa	14
IN - India	10
NL - Olanda	10
SE - Svezia	10
CA - Canada	8
FI - Finlandia	6
ID - Indonesia	6
AT - Austria	5
BD - Bangladesh	5
PL - Polonia	5
SA - Arabia Saudita	5
TR - Turchia	5
BE - Belgio	4
CI - Costa d'Avorio	4
ES - Italia	4
LB - Libano	4
PH - Filippine	4
PK - Pakistan	4
AR - Argentina	3
ET - Etiopia	3
JM - Giamaica	3
KR - Corea	3
LT - Lituania	3
MX - Messico	3
NP - Nepal	3
GP - Guadalupe	2
HN - Honduras	2
IQ - Iraq	2
JP - Giappone	2
KE - Kenya	2
MA - Marocco	2
MY - Malesia	2
RW - Ruanda	2
TH - Thailandia	2
TW - Taiwan	2
UZ - Uzbekistan	2
VE - Venezuela	2
AL - Albania	1
AO - Angola	1
BH - Bahrain	1
BN - Brunei Darussalam	1
BO - Bolivia	1
BY - Bielorussia	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
DK - Danimarca	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
IL - Israele	1
JO - Giordania	1
KY - Cayman, isole	1
LK - Sri Lanka	1
MT - Malta	1
NI - Nicaragua	1
OM - Oman	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
QA - Qatar	1
SC - Seychelles	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
UY - Uruguay	1
Totale	1.398

Nome	#
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses	217
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis	181
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling	178
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases	170
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth	166
Chemical Markers in Italian Propolis: Chrysin, Galangin and CAPE as Indicators of Geographic Origin	159
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis	143
UNIPR1331: SMALL EPH/EPHRIN ANTAGONIST BENEFICIAL IN INTESTINAL INFLAMMATION BY INTERFERING WITH TYPE-B SIGNALLING	109
Protection by Eph/ephrin antagonists against TNBS-induced colitis: effects of the route of administration	78
Pharmacological modulation of the EphA/ephrin-A system and of the CCR6/CCL20 axis in intestinal inflammation	20
Totale	1.421

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	47	0	0	0	0	15	12	1	3	7	3	2	4
2022/2023	85	3	5	6	5	6	10	5	6	22	0	9	8
2023/2024	89	2	5	11	5	5	11	6	12	3	3	5	21
2024/2025	394	15	6	21	39	57	39	36	24	46	34	24	53
2025/2026	633	55	47	93	50	76	38	49	28	97	49	30	21
2026/2027	143	22	39	27	55	0	0	0	0	0	0	0	0
Totale													1.421